治疗近视性冠状腺新血管化的不同方法:一个网络 分析
Ya-Jun Wu1,2,3, Yu-Liang Feng1,2,3, Jia-Song Yang1,2,3
1Aier School of Ophthalmology, Central South University, Changsha 410000, Hunan Province, China.
International journal of ophthalmology
|December 19, 2023
概括
抗血管内皮生长因子 (anti-VEGF) 疗法为近视性冠状腺新血管化 (mCNV) 提供了最佳的长期视力改善. 对mCNV的解剖和功能恢复,抗VEGF药物的静脉内注射比光动力疗法更有效.
科学领域:
- 眼科医生 眼科 眼科
- 视网膜疾病 视网膜疾病
- 医疗治疗 医疗治疗
背景情况:
- 近视性冠状腺新血管化 (mCNV) 是高近视的视力丧失的主要原因.
- 对mCNV的治疗选择包括抗血管内皮生长因子 (抗VEGF) 治疗,光动力学治疗 (PDT) 和激光治疗 (LT).
- 评估这些治疗方法的比较疗效对于优化患者的治疗结果至关重要.
研究的目的:
- 为了比较内抗VEGF剂,PDT和LT在改善mCNV患者视力敏度和视网膜厚度方面的疗效.
- 评估这些治疗对二次结果,如胆管缩 (CRA) 的影响.
主要方法:
- 在主要数据库 (PubMed,Cochrane Library,Web of Science) 进行了系统的文献搜索,截至2023年1月30日.
- 包括比较最佳校正视敏度 (BCVA) 和叶中心厚度 (FCT) 治疗后变化的研究.
- 冠状腺缩 (CRA) 被分析为二次结果指标.
主要成果:
- 在随机对照试验 (RCT) 中,静脉内贝瓦西祖马布 (IVB) 和拉尼祖马布 (IVR) 与PDT相比,表现出优异的BCVA改善.
- 对于BCVA改善的相对有效性通常是IVR> 内阿弗利塞普特 (IVA) > IVB> LT> PDT.
- 对于FCT改善,顺序是IVA>IVR>IVB>PDT,在回顾性研究中观察到类似的趋势.
结论:
- 抗VEGF疗法,特别是内注射,对于mCNV的长期视力改善是最有效的.
- 用IVB或IVR单一治疗可能比对mCNV使用PDT的联合治疗更有益.
- 不同的抗VEGF药物之间在视敏度,黄斑或CRA改善方面没有发现显著差异.
关键词:
一个自由的接受.这是bevacizumab的治疗方法.这就是Conbercept的概念.激光治疗是激光治疗的方法.眼睛近视的冠状腺新血管化.光动力学疗法是一种光动力学疗法.拉尼比祖马布拉尼尼比祖马布拉尼更多相关视频
09:56In Vivo Multimodal Imaging and Analysis of Mouse Laser-Induced Choroidal Neovascularization Model
Published on: January 21, 2018
9.2K
07:18Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography
Published on: February 18, 2022
1.8K
相关概念视频
Open Angle Glaucoma: Treatment
455
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
455
Angle Closure Glaucoma: Treatment
514
Angle-closure glaucoma, or closed-angle glaucoma, is an eye condition where the iris bulges out and blocks the iridocorneal angle, resulting in a buildup of aqueous humor and increased intraocular pressure. Immediate medical attention is necessary due to the sudden onset of symptoms. The treatment for angle-closure glaucoma includes short-term and long-term approaches. Short-term treatment involves using eye drops like pilocarpine to lower intraocular pressure by increasing aqueous humor...
514
